Tag Archives: Medicines for Malaria Venture


Today Economic times reported that Ranbaxy received conditional approval for combination of its NCE molecule (Arterolane) and piperaquine phosphate. Drug Controller General of India ( DCGI) Surinder Singh said the marketing licence was subject to the condition that the Chinese plant … Continue reading

Posted in Daily interesting IP news, Drug developments & targets | Tagged , , , | 1 Comment